MacroGenics, Inc.
MGNX
$3.08
-$0.02-0.65%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 8.21% | -70.13% | 34.88% | 21.37% | 66.53% |
| Total Depreciation and Amortization | -16.95% | -2.51% | 5.30% | -3.80% | 8.05% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 108.42% | -43.90% | -31.18% | -5.19% | -909.72% |
| Change in Net Operating Assets | 1,921.30% | -1,170.33% | -662.40% | -8,106.71% | -79.33% |
| Cash from Operations | 212.01% | -150.17% | -5.62% | -2.73% | -36.99% |
| Capital Expenditure | 60.65% | 28.04% | 30.92% | 63.74% | 0.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -256.24% | -155.23% | -176.30% | -60.27% | 6.71% |
| Cash from Investing | -259.14% | -157.22% | -179.34% | -60.06% | 6.81% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -60.38% | -100.00% | -89.54% | -- | -41.97% |
| Repurchase of Common Stock | -50.00% | 100.00% | 100.00% | 88.21% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -63.23% | 100.00% | 11,058.24% | -213.71% | -43.22% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -812.66% | -152.83% | -516.10% | -80.91% | -70.93% |